330 related articles for article (PubMed ID: 9420038)
1. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
[TBL] [Abstract][Full Text] [Related]
2. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
3. Potency and Stereoselectivity of Cyclopropavir Triphosphate Action on Human Cytomegalovirus DNA Polymerase.
Chen H; Li C; Zemlicka J; Gentry BG; Bowlin TL; Coen DM
Antimicrob Agents Chemother; 2016 Jul; 60(7):4176-82. PubMed ID: 27139481
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.
Biron KK; Harvey RJ; Chamberlain SC; Good SS; Smith AA; Davis MG; Talarico CL; Miller WH; Ferris R; Dornsife RE; Stanat SC; Drach JC; Townsend LB; Koszalka GW
Antimicrob Agents Chemother; 2002 Aug; 46(8):2365-72. PubMed ID: 12121906
[TBL] [Abstract][Full Text] [Related]
5. Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein.
Talarico CL; Burnette TC; Miller WH; Smith SL; Davis MG; Stanat SC; Ng TI; He Z; Coen DM; Roizman B; Biron KK
Antimicrob Agents Chemother; 1999 Aug; 43(8):1941-6. PubMed ID: 10428917
[TBL] [Abstract][Full Text] [Related]
6. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
Cihlar T; Fuller MD; Mulato AS; Cherrington JM
Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects by combination of ganciclovir and tricin on human cytomegalovirus replication in vitro.
Yamada R; Suda H; Sadanari H; Matsubara K; Tuchida Y; Murayama T
Antiviral Res; 2016 Jan; 125():79-83. PubMed ID: 26640224
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
O'Brien MS; Markovich KC; Selleseth D; DeVita AV; Sethna P; Gentry BG
Antiviral Res; 2018 Oct; 158():255-263. PubMed ID: 30153445
[TBL] [Abstract][Full Text] [Related]
9. The immunosuppressive agent mycophenolate mofetil markedly potentiates the activity of lobucavir [1R(1alpha,2beta,3alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine against different herpes viruses.
Neyts J; De Clercq E
Transplantation; 1999 Mar; 67(5):760-4. PubMed ID: 10096537
[TBL] [Abstract][Full Text] [Related]
10. Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants.
Baldanti F; Sarasini A; Drach JC; Zemlicka J; Gerna G
Antiviral Res; 2002 Dec; 56(3):273-8. PubMed ID: 12406510
[TBL] [Abstract][Full Text] [Related]
11. (+-)-(1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)-cyclobutyl] guanine [(+-)-BHCG or SQ 33,054]: a potent and selective inhibitor of herpesviruses.
Field AK; Tuomari AV; McGeever-Rubin B; Terry BJ; Mazina KE; Haffey ML; Hagen ME; Clark JM; Braitman A; Slusarchyk WA
Antiviral Res; 1990 Jan; 13(1):41-52. PubMed ID: 2159261
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the in vitro sensitivity to cidofovir and ganciclovir of clinical cytomegalovirus isolates. Coordinated Action Group 11].
Houhou-Fidouh N; Mazeron MC; Dewilde A; Thouvenot D; Scieux C; Aissa N; Carquin J; Freymuth F
Pathol Biol (Paris); 1998 Jun; 46(6):420-2. PubMed ID: 9769874
[TBL] [Abstract][Full Text] [Related]
13. Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97.
Gentry BG; Vollmer LE; Hall ED; Borysko KZ; Zemlicka J; Kamil JP; Drach JC
Antimicrob Agents Chemother; 2013 Sep; 57(9):4343-8. PubMed ID: 23817384
[TBL] [Abstract][Full Text] [Related]
14. Pentostatin antagonizes the antiviral activity of MBX-2168 by inhibiting the biosynthesis of the active compound.
Hagen NR; Nguyen ML; Williams JD; Bowlin TL; Gentry BG
Antiviral Res; 2021 Mar; 187():105018. PubMed ID: 33476709
[TBL] [Abstract][Full Text] [Related]
15. Drug targets in cytomegalovirus infection.
Andrei G; De Clercq E; Snoeck R
Infect Disord Drug Targets; 2009 Apr; 9(2):201-22. PubMed ID: 19275707
[TBL] [Abstract][Full Text] [Related]
16. PD0084430: a non-nucleoside inhibitor of human cytomegalovirus replication in vitro.
Meyer AL; Bruening EE; Dunkle WE; Booth RJ; Steinbaugh BA; Vara Prasad JV
Antiviral Res; 2001 Dec; 52(3):289-300. PubMed ID: 11675146
[TBL] [Abstract][Full Text] [Related]
17. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
[TBL] [Abstract][Full Text] [Related]
18. Comparison of human cytomegalovirus DNA polymerase activity for ganciclovir-resistant and -sensitive clinical strains.
Kariya M; Mori S; Eizuru Y
Antiviral Res; 2000 Feb; 45(2):115-22. PubMed ID: 10809020
[TBL] [Abstract][Full Text] [Related]
19. The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease.
Hussein ITM; Brooks J; Bowlin TL
Antiviral Res; 2020 Apr; 176():104710. PubMed ID: 31940473
[TBL] [Abstract][Full Text] [Related]
20. Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.
Bhave S; Elford H; McVoy MA
Antiviral Res; 2013 Oct; 100(1):151-8. PubMed ID: 23933116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]